Linear IgA Disease of the Gingiva Following Nivolumab Therapy. (Record no. 4454)

MARC details
000 -LEADER
fixed length control field 02518nam a22004937a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190724s20192019 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1524-9557
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/CJI.0000000000000288 [doi]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 31246639
245 ## - TITLE STATEMENT
Title Linear IgA Disease of the Gingiva Following Nivolumab Therapy.
251 ## - Source
Source Journal of Immunotherapy. 42(9):345-347, 2019 Nov/Dec.
252 ## - Abbreviated Source
Abbreviated source J Immunother. 42(9):345-347, 2019 Nov/Dec.
252 ## - Abbreviated Source
Former abbreviated source J Immunother. 2019 Jun 25
253 ## - Journal Name
Journal name Journal of immunotherapy (Hagerstown, Md. : 1997)
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2019
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2020
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
266 ## - Date added to catalog
Date added to catalog 2019-07-24
268 ## - Previous citation
-- Journal of Immunotherapy. 2019 Jun 25
269 ## - Original dates
Original fiscal year FY2019
501 ## - WITH NOTE
Local holdings Available online from MWHC library: 2000 - present
520 ## - SUMMARY, ETC.
Abstract Immunotherapy has advanced the treatment of solid organ malignancies. Although generally well tolerated, treatment with immune checkpoint inhibitors can be complicated by immune-related adverse events, some of which are relatively uncommon. We report the first case of gingival linear immunoglobulin A disease related to treatment with an antiprogrammed cell death protein 1 antibody. A 73-year-old male with advanced non-small cell lung cancer achieved a durable response to nivolumab monotherapy. After 1 year of treatment, he developed gingival swelling and pain. Biopsy revealed linear immunoglobulin A disease of the gingiva which was effectively treated with systemic steroids. Ongoing vigilance for immune-mediated toxicity is paramount during and after treatment with immune checkpoint inhibitors.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Antineoplastic Agents, Immunological/ae [Adverse Effects]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Gingival Diseases/et [Etiology]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Immunoglobulin A
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Nivolumab/ae [Adverse Effects]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Non-Small-Cell Lung/dt [Drug Therapy]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms/dt [Drug Therapy]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar St Mary's Hospital
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Otolaryngology
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors DeKlotz, Timothy R
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Khan, Amir
790 ## - Authors
All authors DeKlotz T, Gibney GT, Jonna S, Khan A, Lakshmanan S, Lanasa D, Liu SV, Neiders M
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1097/CJI.0000000000000288">https://dx.doi.org/10.1097/CJI.0000000000000288</a>
Public note https://dx.doi.org/10.1097/CJI.0000000000000288
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 07/24/2019   31246639 31246639 07/24/2019 07/24/2019 Journal Article

Powered by Koha